0001225208-16-043118.txt : 20161213
0001225208-16-043118.hdr.sgml : 20161213
20161213185106
ACCESSION NUMBER: 0001225208-16-043118
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161209
FILED AS OF DATE: 20161213
DATE AS OF CHANGE: 20161213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeFord John A
CENTRAL INDEX KEY: 0001403373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 162050029
MAIL ADDRESS:
STREET 1: C R BARD INC
STREET 2: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2016-12-09
0000009892
BARD C R INC /NJ/
BCR
0001403373
DeFord John A
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
Sr. VP Sci Tech and Clin Afrs
Common Stock
2016-12-09
4
M
0
3292.0000
186.4250
A
24899.0816
D
Common Stock
2016-12-09
4
S
0
3292.0000
215.0000
D
21607.0816
D
Common Stock
2016-12-12
4
M
0
4663.0000
97.6850
A
26270.0816
D
Common Stock
2016-12-12
4
M
0
4161.0000
136.3700
A
30431.0816
D
Common Stock
2016-12-12
4
M
0
3767.0000
168.8650
A
34198.0816
D
Common Stock
2016-12-12
4
S
0
826.0000
218.8347
D
33372.0816
D
Common Stock
2016-12-12
4
S
0
1977.0000
220.3770
D
31395.0816
D
Common Stock
2016-12-12
4
S
0
4167.0000
216.9804
D
27228.0816
D
Common Stock
2016-12-12
4
S
0
5621.0000
219.6286
D
21607.0816
D
Common Stock
71.3320
I
401(k) Plan
Option (Right to Buy)
186.4250
2016-12-09
4
M
0
3292.0000
0.0000
D
2025-12-09
Common Stock
3292.0000
9879.0000
D
Option (Right to Buy)
168.8650
2016-12-12
4
M
0
3767.0000
0.0000
D
2024-12-10
Common Stock
3767.0000
7535.0000
D
Option (Right to Buy)
136.3700
2016-12-12
4
M
0
4161.0000
0.0000
D
2023-12-11
Common Stock
4161.0000
4161.0000
D
Option (Right to Buy)
97.6850
2016-12-12
4
M
0
4663.0000
0.0000
D
2022-12-12
Common Stock
4663.0000
0.0000
D
Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Includes 0.0632 shares acquired under the Company's Dividend Reinvestment Plan from July 30, 2016 to November 4, 2016. Includes 0.001 shares acquired under the Company's Employee Stock Purchase Plan from August 2, 2016 to November 7, 2016.
Represents the weighted average sales price for price increments ranging from $218.17 to $219.10. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $220.18 to $220.78. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $216.62 to $217.23. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $219.18 to $220.17. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 0.101 shares acquired under the Company's 401(k) Plan from July 30, 2016 to November 4, 2016.
Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Of this option grant 3,292 options vested on December 9, 2016 and the remaining options vest in three annual installments beginning on December 9, 2017.
Of this option grant 3,767 options vested on December 10, 2016 and the remaining options vest in two annual installments beginning on December 10, 2017.
Of this option grant 4,161 options vested on December 11, 2016 and the remaining options vest on December 11, 2017.
Options fully vested and are currently exercisable.
Myra McGinley, Attorney-in-Fact
2016-12-13